Skip to content

Now that I have gathered all the necessary information, I'll review the GO-CAM model gomodel:66187e4700002082 "The erythropoietin-mediated signaling pathway (Human)".

Review of GO-CAM Model: The erythropoietin-mediated signaling pathway (Human)

gomodel:66187e4700002082

Summary of the Model

This model represents the erythropoietin-mediated signaling pathway in humans. It captures: - Erythropoietin (EPO) acting as a cytokine in the extracellular space - EPO binding to and activating the EPO receptor (EPOR) on the plasma membrane - EPOR activation leading to JAK2 tyrosine kinase activity - JAK2 phosphorylating STAT5B, which then acts as a transcription factor in the nucleus

Accuracy and Completeness

Biological Content

The model correctly represents the core aspects of the EPO signaling pathway, which is well-documented in the literature:

  1. EPO Secretion and Location:
  2. EPO (UniProtKB:P01588) is correctly annotated with cytokine activity (GO:0005125)

  3. EPO is properly located in the extracellular space (GO:0005615), which matches the UniProt entry

  4. EPOR Activity and Location:

  5. EPOR (UniProtKB:P19235) is correctly annotated with erythropoietin receptor activity (GO:0004900)
  6. EPOR is appropriately located at the plasma membrane (GO:0005886)

  7. The evidence for EPOR's membrane location (ECO:0000250) is supported by the UniProt entry

  8. JAK2 Activation:

  9. JAK2 (UniProtKB:O60674) is correctly annotated with non-membrane spanning protein tyrosine kinase activity (GO:0004715)
  10. JAK2 is correctly located at the extrinsic component of cytoplasmic side of plasma membrane (GO:0031234)

  11. The papers cited (PMID:9657743 and PMID:8007942) support that JAK2 associates with cytokine receptors and is activated by EPO

  12. STAT5B Activation and Nuclear Translocation:

  13. STAT5B (UniProtKB:P51692) is correctly annotated with DNA-binding transcription factor activity (GO:0003700)
  14. STAT5B is properly located in the nucleus (GO:0005634)
  15. The activation pathway from JAK2 to STAT5B is supported by PMID:9657743, which shows EPO induces tyrosine phosphorylation of JAK2, STAT5A, and STAT5B

Causal Relationships in the Model

The causal relationships in the model accurately reflect the biological pathway:

  1. EPO directly positively regulates (RO:0002629) the activity of EPOR
  2. EPOR activity uses (RO:0002407) JAK2 activity
  3. JAK2 activity directly positively regulates (RO:0002629) STAT5B activity

These relationships are consistent with the literature. According to PMID:9774108 and PMID:9657743, EPO binds to EPOR, leading to JAK2 activation, which then phosphorylates STAT5, allowing it to dimerize and translocate to the nucleus.

Molecular Quality Control

Proper Use of GO Terms

The model uses appropriate GO terms for each molecule:

  • EPO: Cytokine activity (GO:0005125) - Appropriate for its function
  • EPOR: Erythropoietin receptor activity (GO:0004900) - Specific and accurate
  • JAK2: Non-membrane spanning protein tyrosine kinase activity (GO:0004715) - Correctly describes JAK2's enzymatic function
  • STAT5B: DNA-binding transcription factor activity (GO:0003700) - Accurate for its role in the nucleus

Appropriate Evidence

Each activity in the model is supported by experimental evidence:

  • EPO cytokine activity: ECO:0000314 (direct assay) with PMID:9774108
  • EPOR receptor activity: ECO:0000314 (direct assay) with PMID:2163696
  • JAK2 kinase activity: ECO:0000314 (direct assay) with PMID:9657743
  • STAT5B transcription factor activity: ECO:0000304 (author statement) with PMID:8631883

The evidence codes are appropriate for the types of experimental data cited.

Cellular Locations

The cellular locations are correctly specified:

  • EPO in extracellular space (GO:0005615)
  • EPOR at plasma membrane (GO:0005886)
  • JAK2 at cytoplasmic side of plasma membrane (GO:0031234)
  • STAT5B in nucleus (GO:0005634)

These locations accurately reflect the biology of the pathway.

Conformance to GO-CAM Curation Practices

The model follows GO-CAM best practices: - It uses appropriate causal relationships between activities - Each activity is assigned to the correct molecule - Cellular locations are specified - All activities are part of the erythropoietin-mediated signaling pathway (GO:0038162) - Evidence is provided for each annotation

The model correctly handles complex representation by attributing activities to the specific proteins carrying them, rather than to the entire complex, following the guidelines in the "How to annotate complexes in GO-CAM" document.

Areas for Improvement

While the model is scientifically accurate, there are a few areas that could be enhanced:

  1. Receptor Complex Formation:
  2. EPO binds to EPOR, causing receptor dimerization, which is a critical step for JAK2 activation. The model does not explicitly capture this dimerization event.

  3. According to PMID:9774108, EPO imposes a specific angular relationship (120°) between two EPOR molecules, which is essential for optimal signaling.

  4. STAT5 Dimerization:

  5. After phosphorylation by JAK2, STAT5B forms homodimers or heterodimers with STAT5A, which is an important step for DNA binding and transcriptional activity.

  6. This dimerization and the requirement of tyrosine phosphorylation (at Tyr-699 for STAT5B) for this process are not explicitly represented.

  7. Additional Downstream Events:

  8. The pathway could be extended to include target genes regulated by STAT5B or other downstream effectors activated by JAK2 (like PI3K/AKT pathway).

Conclusion

This GO-CAM model (gomodel:66187e4700002082) accurately represents the core erythropoietin-mediated signaling pathway with appropriate annotations, evidence, and causal relationships. It correctly captures the sequence of events from EPO binding to EPOR, leading to JAK2 activation and STAT5B-mediated transcription.

The model is appropriately concise while capturing the essential features of the pathway. The annotations are well-supported by evidence from the literature, and the causal relationships accurately reflect our understanding of EPO signaling.

While some mechanistic details could be added to enhance the model's completeness, it provides a clear and accurate representation of this important signaling pathway.